How to Help Your Patients Save Money on Astagraf XL: A Provider's Guide to Savings Programs

For transplant nephrologists, transplant coordinators, and social workers managing kidney transplant patients, medication affordability is a direct patient safety issue. Astagraf XL (tacrolimus extended-release capsules) is a brand-only, lifelong medication with retail prices ranging from approximately $95 per month (0.5 mg, 30 capsules) to over $880 per month (5 mg, 30 capsules). Medication non-adherence due to cost is a well-documented cause of transplant rejection -- and it is preventable.

This guide reviews all available Astagraf XL savings programs, how to enroll patients, and practical recommendations for building cost management into your transplant follow-up workflow.

The Cost Problem: Why Astagraf XL Affordability Matters Clinically

Astagraf XL is brand-only with no currently commercially available generic. While the FDA has approved a generic version of tacrolimus XR, it has not yet reached the market. Until it does, all patients on Astagraf XL are paying brand-name prices. For uninsured patients, out-of-pocket monthly costs can reach hundreds to thousands of dollars depending on dose -- costs that can drive non-adherence.

Proactive financial screening and enrollment in savings programs at transplant discharge -- and at every follow-up -- should be a standard component of transplant care coordination.

Program 1: Astellas Cares Copay Card (Commercially Insured Patients)

The Astellas Cares Copay Card is the most impactful savings tool for commercially insured patients taking Astagraf XL:

• Benefit: Reduces out-of-pocket copay to as little as $0, with annual savings up to $3,000
• Eligibility: Must have commercial (private) prescription drug insurance for Astagraf XL
• Exclusions: Medicare, Medicaid, VA, DoD, TRICARE, or other government programs
• Duration: 12 months; requires annual re-enrollment -- this is a critical reminder for transplant coordinators
• How to enroll: astellascares.com or 1-800-727-7003. Patients can enroll at the pharmacy or online.

Clinical workflow recommendation: At transplant discharge, have your transplant coordinator or social worker screen every commercially insured patient for copay card eligibility and assist with enrollment before the patient leaves the hospital. Add an annual re-enrollment reminder to your post-transplant follow-up protocol.

Program 2: Astellas Cares Patient Assistance Program (Uninsured Patients)

For uninsured patients who meet income eligibility criteria, the Astellas Cares Patient Assistance Program can provide Astagraf XL at no cost. This is especially important for low-income post-transplant patients who do not qualify for Medicaid and lack commercial coverage.

Enrollment and eligibility verification: Contact Astellas Cares at 1-800-727-7003 or visit astellascares.com. Your transplant social worker can facilitate the application process.

Program 3: Medicare Coverage -- Part B and Part D

Astagraf XL is covered by Medicare Part B as an immunosuppressive drug used after solid organ transplant for patients whose Medicare entitlement is based on End-Stage Renal Disease (ESRD). Medicare Part B covers 80% of the allowed amount after the annual Part B deductible ($257 in 2025), leaving a 20% coinsurance. Medicare Part D provides an alternative coverage pathway.

Note for providers: The Consolidated Appropriations Act of 2021 extended Medicare Part B immunosuppressive drug coverage for ESRD kidney transplant recipients indefinitely (previously it ended 36 months post-transplant). This is a critical update that significantly improves long-term access for Medicare patients.

Program 4: Medicare Extra Help / Low-Income Subsidy

Medicare Part D patients with limited income and resources may qualify for Extra Help (Low-Income Subsidy). Eligible patients pay no more than $4.50 for generic drugs or $11.20 for brand-name drugs per prescription in 2025. Providers should routinely screen post-transplant Medicare patients for Extra Help eligibility and refer them to Social Security (ssa.gov) or their State Health Insurance Assistance Program (SHIP) for enrollment assistance.

Program 5: Nonprofit and Community Resources

For patients who fall into gaps between insurance programs, these nonprofits provide medication assistance:

• American Kidney Fund (AKF): Provides grants to help transplant patients cover insurance premiums and medication costs. kidneyfund.org
• RxOutreach: Nonprofit mail-order pharmacy offering Astagraf XL at low cost with free delivery. Phone: 314-222-0472
• NeedyMeds.org: Comprehensive database of manufacturer PAPs and assistance programs
• RxAssist: Detailed directory of pharmaceutical company PAPs for transplant social workers to reference

Building a Financial Assistance Workflow for Your Transplant Program

Recommended workflow for transplant programs managing Astagraf XL patients:

1. Pre-discharge financial screening: Screen all patients for insurance type, income, and copay assistance eligibility
2. Copay card enrollment at discharge: Enroll eligible commercial patients in the Astellas Cares Copay Card before discharge
3. Annual re-enrollment reminders: Flag copay card expiration in the care management system and proactively contact patients
4. Medicare Part B verification: Confirm all eligible patients have Astagraf XL billed under Part B and are aware of the indefinite coverage extension
5. Adherence monitoring: Unexpected drops in tacrolimus trough levels can signal non-adherence due to cost -- ask patients about medication affordability at every visit

Bottom Line for Transplant Providers

Astagraf XL affordability is a patient safety issue, not just a billing matter. With the right savings programs in place, most patients can dramatically reduce or eliminate their out-of-pocket costs. Integrating financial assistance enrollment into your standard transplant care workflow protects both your patients and the organs they worked so hard to receive. For help ensuring patients can also find Astagraf XL in stock, see our provider guide to helping patients find Astagraf XL or visit medfinder for providers.